You are here
P&T News
April 23
Medical Device Enables Nerve Stimulation During Sleep
May Offer Improved Safety Profile for Pediatric Patients
Hope for Sufferers With Post-Treatment Lyme Disease Syndrome
KardiaMobile Receives Two More Clearances for Arrhythmia Detection
April 18
New Hematologic Biomarker Test Provides New Approach to Sepsis Triage and Diagnosis
Enables Faster Alerts for Consumers
Antibiotics, Statins, and Glucocorticoids All Show Promise
Possible First Treatment Option for Rare Autoimmune Disease of the CNS
April 16
Current, Sole Therapy Not Always Successful/Suitable
Over 1.5 Million Americans Likely to have Wet AMD by 2020
Potential For Use Against E. Coli, TB, Resistant Bacteria
More Than 32% of Patients Responded in Trial
April 11
Potential to Impact Key NASH Markers
Evenity Increases New Bone Formation, Lowers Vertebral Fracture Potential
Drug Improved or Stabilized Symptoms, Shrank Brain Lesions
Drug Candidate May Prevent Virus From Fusing With Epithelial Cells, B Cells
April 9
Dovato Achieved Non-inferior Efficacy Compared to Traditional Regimen; No Cases of Resistance
Optogenetics Provides Insights Into Basis of Fear, Addiction
First Patient Expected to Receive AMT-130 Therapy in 2019
START Study Startles Researchers
April 4
Engineered MDC1 Cells Reverse Latency
Benralizumab Dramatically Improved
LAMA/LABA Population Expected to Grow Rapidly in Coming Years
Currently Incurable RRP Affects 20,000 Cases in the U.S.
April 2
Incurable Genetic Condition Affects One in 3-4,000 People
First-in-Human Phase 1 Trial Will Begin This Year
Aggressive T-cell Prolymphocytic Leukemia Has Very Limited Treatment Options
Approximately 250,000 People in the U.S. Live with PI
March 28
Subcutaneous Agent Could Prevent Laparoscopic Surgery, Emergency Surgery
Majority of Trial Patients Achieved Normal Testoserone Levels